Larvol Delta - Abscireported-interim-Phase-1-data-from-the-HEADLINE-trial-for-ABS201-which-reported-positive-results-on-safety-and-pharmacokinetics

ABS-201 - Absci Corp

https://www.bitget.com/news/detail/12560605485278

Jul 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next